Current measures for the evaluation of acne severity

Expert Review of Dermatology

Volumn 3, Issue 5, 2008, Pages 595-603

  Tan, Jerry K L ^a,b,c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b WINDSOR REGIONAL HOSPITAL   (Canada)

^c Windsor Clinical Research Inc   (Canada)

Author keywords

Acne; Background; Evaluation; Global scores; Grading; Lesion count; Measure; Quality of life; Scar; Severity

Indexed keywords

ACNE; ACNE VULGARIS; ANXIETY; BODY IMAGE; CLINICAL EVALUATION; CLINICAL EXAMINATION; CLINICAL FEATURE; DEPRESSION; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; KELOID; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; REVIEW; SCORING SYSTEM; SKIN DEFECT; SKIN DISEASE; SKIN SCAR; SOCIAL ISOLATION; SOCIAL PSYCHOLOGY; SOMATIZATION; SUICIDAL IDEATION;

EID: 55249108730     PISSN: 17469872     EISSN: None     Source Type: Journal    
DOI: 10.1586/17469872.3.5.595     Document Type: Review

References (39)

1. Lello J, Pearl A, Arroll B, Yallop J, Birchall NM. Prevalence of acne vulgaris in Auckland senior high school students. NZ Med. J. 108, 287-289 (1995).
2. Collier CN, Harper JC, Cafardi JA et al. The prevalence of acne in adults 20 years and older. J. Am. Acad. Dermatol. 58, 56-59 (2008).
3. Stern RS. The prevalence of acne on the basis of physical examination, J. Am. Acad. Dermatol. 26, 931-935 (1992).
4. Stern RS. Acne therapy, medication use and sources of care in office-based practice. Arch. Dermatol. 132, 776-780 (1996).
5. Lehmann HL, Robinson KA, Andrews JS, Holloway V, Goddinan SN. Acne therapy: a methodological review. J. Am. Acad. Dermatol. 47, 231-240 (2002).
6. Stathakis V, Kilkenny M, Marks R. Descriptive epidemiology of acne vulgaris in the community. Australas J. Dermatol. 38, 115-123 (1997).
7. Pochi PE, Shalita AR, Strauss JS, Webster SB. Report of the consensus conference on acne classification. J. Am. Acad. Dermatol. 24, 495-500 (1991).
8. US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER). Guidance for Industry; AcneVulgaris: Developing Drugs for Treatment (2005).
9. Witkowski JA, Simons HM. Objective evaluation of demethychlortetracycline hydrocholoride in the treatment of acne. JAMA 196, 397-400 (1996).
10. Cook CH, Centner RL, Michaels SE. An acne grading method using photographic standards. Arch. Dermatol. 115, 571-575 (1979).
11. Streiner DL, Norman GR. Health Measurement Scales: a Practical Guide to their Development and Use. Oxford University Press, Oxford, UK (1989).
12. Lucky AW, Barber BL, Girman CJ, Williams J, Ratterman J, Waldstreicher J. A multirater validation study to assess the reliability of acne lesion counting. J. Am. Acad. Dermatol. 35, 559-565 (1996).
13. Tan JK, Fung K, Bulger L. Reliability of dermatologists in acne lesion counts and global assessments. J. Cutan. Med. Surg. 10, 160-165 (2006).
14. Tan JKL, Tang J, Fung K et al. Development and validation of a comprehensive acne severity scale (CASS). J. Cutan. Med. Surg. 11, 211-216 (2007).
15. Witkowski JA, Parish LC. The assessment of acne: an evaluation of grading and lesion counting in the measurement of acne. Clin. Dermatol. 22, 394-397 (2004).
16. O'Brien SC, Lewis JB, Cunliffe WJ. The Leeds revised acne grading system. J. Dermatolog. Treat. 9, 215-220 (1998).
17. Doshi A, Zaheer A, Stiller M. A comparison of current acne grading systems and proposal of a novel system. Int. J. Dermatol. 36, 416-418 (1997).
18. Allen BS, Smith G Jr. Various parameters for grading acne vulgaris. Arch. Dermatol. 118, 23-25 (1982).
19. Hayashi N, Akamatsu H, Kawashima M. Establishment of grading criteria for acne severity. J. Dermatol. 35, 255-260 (2008).
20. Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clin. Exper. Dermatol. 19, 303-308 (1994).
21. Dreno B, Khammari A, Orain N et al. ECCA grading scale: an original validated acne scar grading scale for clinical practice in dermatology. Dermatology 214, 46-51 (2007).
22. Goodman GJ, Baron JA. The management of postacne scarring. Dermatol. Surg. 33, 1175-1188 (2007).
23. Goodman GJ, Baron JA. Postacne scarring: a qualitative global scarring grading system. Dermatol. Surg. 32, 1458-1466 (2006).
24. Tan JKL, Li Y, Fung K et al. Divergence of demographic factors associated with clinical severity compared to QoL impact in acne. J. Cutan. Med. Surg. (In Press) (2008).
25. Mallon E, Newton JN, Klassen A et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br. J. Dermatol. 140(4), 672-676 (1999).
26. Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br. J. Dermatol. 140(2), 273-282 (1999).
27. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br. J. Dermatol. 139(5), 846-850 (1998).
28. Krowchuk DP, Stancin T, Keskinen R, Walker R, Bass J, Anglin TM. The psychosocial effects of acne on adolescents. Pediatr. Dermatol. 8(4), 332-338 (1991).
29. Van der Meeren HLM, van der Schaar WW, van den Hurk CMAM. The psychological impact of severe acne. Cutis 36(1), 84-86 (1985).
30. Demircay Z, Seckin D, Senol A, Demir F. Patient's perspective: an important issue not to be overlooked in assessing acne severity. Eur. J. Dermatol. 18, 181-184 (2008).
31. Salek MS, Khan GK, Finlay AY. Questionnaire techniques in assessing acne handicap: reliability and validity study. Qual. Life Res. 5, 131-138 (1996).
32. Layton AM, Seukeran D, Cunliffe WJ. Scarred for life? Dermatology 195 (Suppl. 1), 15-21 (1997).
33. Motley RJ, Findlay AY. How much disability is caused by acne? Clin. Exp. Derm. 14, 194-198 (1989).
34. Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin. Exp. Dermatol. 17, 1-3 (1992).
35. Gupta M, Johnson AM, Gupta AK. The development of an acne quality of life scale: reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm. Venereol. 78, 451-456 (1998).
36. Girman CJ, Hartmaier S, Thiboutot D et al. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual. Life Res. 5, 481-490 (1996).
37. Martin AR, Lookingbill DP, Botek A, Light J, Thiboutot D, Girman CJ. Health-related quality of life among patients with facial acne - assessment of a new acne-specific questionnaire. Clin. Exp. Dermatol. 26, 380-385 (2001).
38. Fehnel SE, McLeod LD, Brandman J et al. Responsiveness of the acne-specific quality of life questionnaire (Acne-QoL to treatment for acne vulgaris in placebo-controlled clinical trials. Qual. Life Res. 11, 809-816 (2002).
39. Tan J, Fung KY, Khan S. Condensation and validation of a 4-item index of the Acne-QoL. Qual. Life Res. 15, 1203-1210 (2006).